GSK plc
GLAXFOTCHealthcare● Active
$23.54
$-0.40(-1.67%)
Market Cap$94.4B
P/E Ratio—
52W High$31.48
52W Low$17.15
GSK plc（GLAXF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GLAXF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $5.72B | $2.95B | $5.31B | $4.92B | $5.10B |
| Depreciation & Amort. | $3.78B | $2.55B | $2.29B | $2.30B | $2.52B |
| Stock-Based Comp. | $0.00B | $0.34B | $0.31B | $0.35B | $0.34B |
| Change in Working Capital | ($0.62B) | $2.09B | ($0.36B) | $0.27B | ($0.47B) |
| Net Cash from Operations | $7.30B | $6.55B | $6.77B | $7.40B | $7.95B |
| Investing Activities | |||||
| Capital Expenditure | ($1.35B) | ($2.98B) | ($2.34B) | ($2.26B) | ($2.93B) |
| Purchases of Investments | ($0.09B) | $0.00B | $0.00B | ($0.70B) | $1.76B |
| Sales of Investments | $0.20B | $0.02B | $0.07B | $0.00B | $0.02B |
| Net Cash from Investing | ($5.85B) | ($1.23B) | ($1.59B) | ($8.77B) | ($1.78B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($2.56B) | ($2.44B) | ($2.25B) | ($3.47B) | ($4.00B) |
| Debt Issued / Repaid | $1.51B | ($1.17B) | ($2.39B) | ($4.62B) | ($2.00B) |
| Net Cash from Financing | ($1.63B) | ($4.73B) | ($5.64B) | $0.82B | ($7.59B) |
| Free Cash Flow | |||||
| Free Cash Flow | $5.95B | $3.57B | $4.42B | $5.14B | $5.02B |
| FCF Margin %(computed) | 18.23% | 11.38% | 14.59% | 17.55% | 14.72% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · GBP · B
深入了解GSK plc
关于GSK plc（GLAXF）现金流量表
GSK plc 2025财年经营活动现金流$7.30B，自由现金流$5.95B（FCF利润率18.23%），资本支出($1.35B)。
常见问题
GLAXF · 4 问GSK plc 2025财年自由现金流$5.95B，同比up66.7%。
GLAXF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10